More than 200,000 votes helped shape the cast of a live-action game. Players steer the story.

Investing.com reports Snail Inc. (SNAL) shares fell 30.9% in after-hours to $3.17 after Q2 2026 results missed expectations. Revenue was $19.7M, down 11.3% YoY and below a ~$29M consensus. Bookings fell 19.6% to $21.8M and net loss was $3.0M. The sell-off was company-specific.

Snail, Inc. (SNAL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Snail, Inc. Reports Second Quarter 2026 Financial Results CULVER CITY, Calif., August 11, 2026 (GLOBE NEWSWIRE) – Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, t

Meta CEO Mark Zuckerberg announced a $100B-$200B AI investment by 2025, launching Muse Wonder AI models. Meta claims its models rival competitors, with 'active memory' as a key feature. Early demand for the Muse app is strong, with 2.8M downloads in 12 days. Citi estimates potential $27B annual revenue by 2030. Meta's Q2 results showed increased capital spending and reduced free cash flow, raising concerns about costs.

Nvidia CEO Jensen Huang highlighted Europe's potential in AI and robotics, citing its engineering expertise. The company announced expanded partnerships with European firms and committed $10 billion to the region's tech ecosystem. Nvidia also showcased new data center modules and robot demonstrations at its GTC conference in Berlin.

Nvidia Corp. announced Samsung Electro-Mechanics will join its semiconductor substrate supply chain, supporting capacity expansion in South Korea. The multiyear deal, starting in 2026, aims to significantly boost production for AI semiconductors by 2028. Nvidia also plans a 300% increase in interposer wafer capacity with Amkor Technology. The moves are part of Nvidia's global initiative to meet growing AI demand.

GSK reported five-year data for ViiV Healthcare's HIV treatment Cabenuva, showing 77% of participants remained on the treatment and 94% had a last viral load of less than 50 copies per millilitre. The study's lead author and ViiV's CMO highlighted the positive results. GSK shares were up 0.3% in afternoon trading.